Analysis reveals 4.5% prevalence of MEFV gene mutations in children with drug-resistant epilepsy, suggesting minimal influence on occurrence.
The prevalence of MEFV gene mutations in children with DRE was 4.5%, suggesting that these mutations may not significantly influence the occurrence of DRE in this population.
No takes yet. Share an insight, caveat, or question.
Habibi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: